0.25% Trypsin Solution (E-EL-SR001) elabscience
$20.00
In stock
SKU
E-EL-SR001
| Size | Price (USD) |
| 100mL | $20.00 |
Product Details
| Applications | ELISA,Related_Reagents |
Product Description
Introduction: This reagent is used to digest adherent cells during cell extraction/cell lysate sample collection in ELISA experiments.
Assay / Application Information
| Expiration date | 12 months |
Storage and Shipping
| Storage | -20℃ |
- SLC31A1 knockdown mitigates post-MI heart failure via regulation of copper metabolism
Journal: Frontiers in Immunology | Year: 2026 | Impact Factor: 5.900
DOI: 10.3389/fimmu.2026.1707203 | Reactivity: Mouse - The host–guest inclusion complex of Anle 138b with Methyl-β-cyclodextrin: In vitro characterization and possible formulation development for anti-Parkinson application
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS | Year: 2026 | Impact Factor: 5.200
DOI: 10.1016/j.ijpharm.2026.126685 - MARCH6 Confers Protection Against Endoplasmic Reticulum Autophagy in Gliomas by Destabilizing FAM134B
Journal: NEUROCHEMICAL RESEARCH | Year: 2026 | Impact Factor: 3.800
DOI: 10.1007/s11064-026-04684-z - Transcriptomic analysis reveals the regulatory role of LIPE in lipid metabolism and tumor-associated macrophage polarization in breast cancer
Journal: PATHOLOGY RESEARCH AND PRACTICE | Year: 2026 | Impact Factor: 3.700
DOI: 10.1016/j.prp.2026.156515 - PX-12 exhibits cytotoxic and anti-migration effects in colorectal cancer cells under Hypoxia-like conditions induced by Dimethyloxalylglycine
Journal: CYTOTECHNOLOGY | Year: 2026 | Impact Factor: 2.200
DOI: 10.1007/s10616-026-00990-0 - Slightly viscous oxidized alginate dispersions as vehicles for intranasal administration of the α-synuclein aggregation inhibitor Anle 138b in free form or encapsulated in solid lipid nanoparticles
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS | Year: 2025 | Impact Factor: 5.300
DOI: 10.1016/j.ijpharm.2025.125399 - Dopamine and Citicoline-Co-Loaded Solid Lipid Nanoparticles as Multifunctional Nanomedicines for Parkinson’s Disease Treatment by Intranasal Administration
Journal: Pharmaceutics | Year: 2024 | Impact Factor: 4.900
DOI: 10.3390/pharmaceutics16081048 - Protocol for inducing monomicrobial sepsis in mice with uropathogenic E.?coli
Journal: STAR Protocols | Year: 2024 | Impact Factor: 1.300
DOI: 10.1016/j.xpro.2024.103206
MDSD
Reviews
Write Your Own Review